Music therapy, neural processing, and craving reduction: an RCT protocol for a mixed methods feasibility study in a Community Substance Misuse Treatment Service.
Community treatment service
EEG
Feasibility
Mental health
Mixed methods
Music therapy
Neural processing
Randomized controlled trial
Substance use disorder
Journal
Addiction science & clinical practice
ISSN: 1940-0640
Titre abrégé: Addict Sci Clin Pract
Pays: England
ID NLM: 101316917
Informations de publication
Date de publication:
27 05 2023
27 05 2023
Historique:
received:
11
10
2022
accepted:
01
05
2023
medline:
29
5
2023
pubmed:
28
5
2023
entrez:
27
5
2023
Statut:
epublish
Résumé
Music therapy has been shown to be effective for multiple clinical endpoints associated with substance use disorder such as craving reduction, emotion regulation, depression, and anxiety, but there are a lack of studies investigating those effects in UK Community Substance Misuse Treatment Services (CSMTSs). Furthermore, there is a demand for identifying music therapy mechanisms of change and related brain processes for substance use disorder treatment. The present study aims to evaluate the feasibility and acceptability of music therapy and a pre-test, post-test, and in-session measurement battery in a CSMTS. Fifteen participants, from a community service based in London, will take part in a mixed-methods non-blind randomized-controlled trial. Ten participants will receive six-weekly sessions of music therapy in addition to the standard treatment offered by the CSMTS-five of them will receive individual music therapy and five of them will receive group music therapy-while a further five participants will act as a control group receiving standard treatment only. Satisfaction and acceptability will be evaluated in focus groups with service users and staff members following the final treatment session. Moreover, attendance and completion rates will be monitored throughout the intervention. Subjective and behavioral indexes will be assessed before and after the interventions to explore the effects of music therapy on craving, substance use, symptoms of depression and anxiety, inhibitory control, and will be correlated with associated neurophysiological signatures. In-session analysis of two individual music therapy sessions will serve to explore how music and emotion are processed in the brain within the therapy. The data collected at each step will be included in an intention-to-treat analysis basis. This study will provide a first report on the feasibility of music therapy as an intervention for participants with substance use disorder engaged within a community service. It will also provide valuable information regarding the implementation of a multifaceted methodology that includes neurophysiological, questionnaire-based, and behavioral assessments in this cohort. Notwithstanding the limitation of a small sample size, the present study will provide novel preliminary data regarding neurophysiological outcomes in participants with substance use disorder that received music therapy. ClinicalTrails.gov, NCT0518061, Registered 6 January 2022, https://clinicaltrials.gov/ct2/show/NCT05180617.
Sections du résumé
BACKGROUND
Music therapy has been shown to be effective for multiple clinical endpoints associated with substance use disorder such as craving reduction, emotion regulation, depression, and anxiety, but there are a lack of studies investigating those effects in UK Community Substance Misuse Treatment Services (CSMTSs). Furthermore, there is a demand for identifying music therapy mechanisms of change and related brain processes for substance use disorder treatment. The present study aims to evaluate the feasibility and acceptability of music therapy and a pre-test, post-test, and in-session measurement battery in a CSMTS.
METHODS
Fifteen participants, from a community service based in London, will take part in a mixed-methods non-blind randomized-controlled trial. Ten participants will receive six-weekly sessions of music therapy in addition to the standard treatment offered by the CSMTS-five of them will receive individual music therapy and five of them will receive group music therapy-while a further five participants will act as a control group receiving standard treatment only. Satisfaction and acceptability will be evaluated in focus groups with service users and staff members following the final treatment session. Moreover, attendance and completion rates will be monitored throughout the intervention. Subjective and behavioral indexes will be assessed before and after the interventions to explore the effects of music therapy on craving, substance use, symptoms of depression and anxiety, inhibitory control, and will be correlated with associated neurophysiological signatures. In-session analysis of two individual music therapy sessions will serve to explore how music and emotion are processed in the brain within the therapy. The data collected at each step will be included in an intention-to-treat analysis basis.
DISCUSSION
This study will provide a first report on the feasibility of music therapy as an intervention for participants with substance use disorder engaged within a community service. It will also provide valuable information regarding the implementation of a multifaceted methodology that includes neurophysiological, questionnaire-based, and behavioral assessments in this cohort. Notwithstanding the limitation of a small sample size, the present study will provide novel preliminary data regarding neurophysiological outcomes in participants with substance use disorder that received music therapy.
TRIAL REGISTRATION
ClinicalTrails.gov, NCT0518061, Registered 6 January 2022, https://clinicaltrials.gov/ct2/show/NCT05180617.
Identifiants
pubmed: 37245018
doi: 10.1186/s13722-023-00385-y
pii: 10.1186/s13722-023-00385-y
pmc: PMC10225077
doi:
Banques de données
ClinicalTrials.gov
['NCT05180617']
Types de publication
Clinical Trial Protocol
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
36Informations de copyright
© 2023. The Author(s).
Références
Biol Psychol. 2010 Jul;84(3):451-62
pubmed: 19733618
Psychopharmacology (Berl). 2013 Mar;226(2):273-83
pubmed: 23096771
Drug Alcohol Depend. 2012 Sep 1;125(1-2):37-42
pubmed: 22480667
Front Hum Neurosci. 2015 May 01;9:223
pubmed: 25983683
Trends Cogn Sci. 2015 Mar;19(3):111-4
pubmed: 25641075
J Affect Disord. 2004 Jul;81(1):61-6
pubmed: 15183601
PLoS One. 2017 Nov 15;12(11):e0187363
pubmed: 29141012
Biol Psychol. 2005 Jul;69(3):353-73
pubmed: 15925035
PLoS One. 2020 Mar 10;15(3):e0229905
pubmed: 32155186
Psychiatry Res. 2019 Feb;272:569-571
pubmed: 30616125
J Music Ther. 2013 Summer;50(2):93-122
pubmed: 24156189
Int J Psychophysiol. 2004 Jan;51(2):155-80
pubmed: 14693365
Lancet Psychiatry. 2016 Aug;3(8):760-773
pubmed: 27475769
PLoS One. 2016 Mar 15;11(3):e0150205
pubmed: 26978655
Cochrane Database Syst Rev. 2022 May 9;5:CD012576
pubmed: 35532044
Arch Intern Med. 2006 May 22;166(10):1092-7
pubmed: 16717171
Prog Neurobiol. 2008 Nov;86(3):156-85
pubmed: 18824212
Front Hum Neurosci. 2016 Nov 22;10:585
pubmed: 27920673
Front Psychiatry. 2013 Dec 27;4:179
pubmed: 24409155
Subst Abus. 2020;41(4):493-500
pubmed: 31638882
Brain Sci. 2022 Apr 27;12(5):
pubmed: 35624953
J Music Ther. 2017 Nov 01;54(3):287-299
pubmed: 28992114
Trends Cogn Sci. 2013 Apr;17(4):179-93
pubmed: 23541122
Neuroimage. 2005 Oct 15;28(1):175-84
pubmed: 16023376
J Psychother Pract Res. 1996 Summer;5(3):260-71
pubmed: 22700294
Neuropsychopharmacology. 2010 Jan;35(1):217-38
pubmed: 19710631
Harv Rev Psychiatry. 2019 Sep/Oct;27(5):326-331
pubmed: 31385813
Soc Cogn Affect Neurosci. 2021 Jan 18;16(1-2):72-83
pubmed: 33031496
West J Emerg Med. 2017 Oct;18(6):1075-1078
pubmed: 29085540
Annu Rev Neurosci. 2015 Jul 8;38:433-47
pubmed: 25938726
J Music Ther. 2005 Spring;42(1):64-80
pubmed: 15839734
Brain Topogr. 2013 Apr;26(2):338-54
pubmed: 22983820
Addict Behav. 2008 Feb;33(2):381-7
pubmed: 17964079
Neuroimage. 2011 Jul 15;57(2):565-75
pubmed: 21571079
Laterality. 2019 Sep;24(5):505-524
pubmed: 30388061
Front Psychol. 2019 Jul 25;10:1561
pubmed: 31402880
Alcohol Alcohol. 1999 Mar-Apr;34(2):197-222
pubmed: 10344781
Neurosci Lett. 2011 May 27;496(1):5-10
pubmed: 21458537
Cochrane Database Syst Rev. 2017 Nov 16;11:CD004517
pubmed: 29144545
Psychol Sci. 2011 Apr;22(4):498-506
pubmed: 21378368
J Abnorm Psychol. 2006 Nov;115(4):715-29
pubmed: 17100529
J Music Ther. 2011 Winter;48(4):509-31
pubmed: 22506302
Biol Psychiatry. 1983 Jul;18(7):753-62
pubmed: 6615936
Sci Rep. 2018 Jan 17;8(1):923
pubmed: 29343732